Development
SOPHiA GENETICS SA
SOPH
$3.13
$0.082.62%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 62.37M | 58.71M | 54.05M | 50.67M | 47.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 62.37M | 58.71M | 54.05M | 50.67M | 47.56M |
| Cost of Revenue | 19.46M | 18.06M | 17.39M | 16.43M | 16.31M |
| Gross Profit | 42.91M | 40.64M | 36.66M | 34.24M | 31.25M |
| SG&A Expenses | 81.72M | 78.67M | 79.82M | 81.50M | 84.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -983.00K | -1.13M | -299.00K | -481.00K | -450.00K |
| Total Operating Expenses | 137.17M | 129.60M | 132.04M | 132.68M | 135.31M |
| Operating Income | -74.80M | -70.89M | -77.98M | -82.02M | -87.75M |
| Income Before Tax | -78.49M | -68.67M | -78.56M | -81.92M | -87.59M |
| Income Tax Expenses | 487.00K | 221.00K | -183.00K | -262.00K | -136.00K |
| Earnings from Continuing Operations | -78.98 | -68.89 | -78.38 | -81.66 | -87.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -78.98M | -68.89M | -78.38M | -81.66M | -87.45M |
| EBIT | -74.80M | -70.89M | -77.98M | -82.02M | -87.75M |
| EBITDA | -69.46M | -65.69M | -73.29M | -77.73M | -84.16M |
| EPS Basic | -1.22 | -1.07 | -1.22 | -1.27 | -1.36 |
| Normalized Basic EPS | -0.76 | -0.66 | -0.76 | -0.80 | -0.85 |
| EPS Diluted | -1.22 | -1.07 | -1.22 | -1.27 | -1.36 |
| Normalized Diluted EPS | -0.76 | -0.66 | -0.76 | -0.80 | -0.85 |
| Average Basic Shares Outstanding | 258.84M | 258.03M | 257.15M | 256.74M | 256.39M |
| Average Diluted Shares Outstanding | 258.84M | 258.03M | 257.15M | 256.74M | 256.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |